[HTML][HTML] Cell membrane modulation as adjuvant in cancer therapy

S Zalba, TLM Ten Hagen - Cancer treatment reviews, 2017 - Elsevier
Cancer is a complex disease involving numerous biological processes, which can exist in
parallel, can be complementary, or are engaged when needed and as such can replace …

P-glycoprotein inhibition for optimal drug delivery

ML Amin - Drug target insights, 2013 - journals.sagepub.com
P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the
body and is responsible for limiting cellular uptake and the distribution of xenobiotics and …

Coexistence of passive and carrier-mediated processes in drug transport

K Sugano, M Kansy, P Artursson, A Avdeef… - Nature reviews Drug …, 2010 - nature.com
The permeability of biological membranes is one of the most important determinants of the
pharmacokinetic processes of a drug. Although it is often accepted that many drug …

Mammalian ABC transporters in health and disease

P Borst, RO Elferink - Annual review of biochemistry, 2002 - annualreviews.org
▪ Abstract The ATP-binding cassette (ABC) transporters are a family of large proteins in
membranes and are able to transport a variety of compounds through membranes against …

ABC multidrug transporters: structure, function and role in chemoresistance

FJ Sharom - Pharmacogenomics, 2008 - Taylor & Francis
Three ATP-binding cassette (ABC)-superfamily multidrug efflux pumps are known to be
responsible for chemoresistance; P-glycoprotein (ABCB1), MRP1 (ABCC1) and ABCG2 …

ABC efflux pump-based resistance to chemotherapy drugs

PDW Eckford, FJ Sharom - Chemical reviews, 2009 - ACS Publications
Over 1 million new cases of all types of cancer are diagnosed each year in the United States
alone, and 559 650 cancer-related deaths were expected to occur in 2007. 1 …

[HTML][HTML] Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function

FJ Sharom - Frontiers in oncology, 2014 - frontiersin.org
Multidrug resistance in cancer is linked to expression of the P-glycoprotein multidrug
transporter (Pgp, ABCB1), which exports many structurally diverse compounds from cells …

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs

KMM Doan, JE Humphreys, LO Webster… - … of Pharmacology and …, 2002 - ASPET
Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain
barrier penetration. The objectives of this study were to determine whether there are …

Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs

CAS Bergström, R Holm, SA Jørgensen… - European Journal of …, 2014 - Elsevier
Preformulation measurements are used to estimate the fraction absorbed in vivo for orally
administered compounds and thereby allow an early evaluation of the need for enabling …

Rational use of in vitro P-glycoprotein assays in drug discovery

JW Polli, SA Wring, JE Humphreys, L Huang… - … of Pharmacology and …, 2001 - ASPET
P-glycoprotein (Pgp) affects the absorption, distribution, and clearance of a variety of
compounds. Thus, identification of compounds that are Pgp substrates can aid drug …